Advertisement
The new Pharmacor report entitled Atopic Dermatitis finds that genericerosion of antihistamines will cause drug sales in this class to plunge by 61percent from 2007 to 2017. Antihistamines, along with topical calcineurininhibitors and topical corticosteroids, dominate the atopic dermatitis drugmarket, accounting for 96 percent of major market sales in 2007. Topicalcalcineurin inhibitors -- Novartis's Elidel and Astellas's Protopic -- andtopical corticosteroids are the primary treatment options used to treat thechronic skin disorder.
Advertisement
The report finds that the generic erosion of all major drug classes inatopic dermatitis and the dearth of effective emerging agents will cause themarket to decline from $706.5 million in 2007 to just over $552 million in2017.
"While most interviewed physicians indicate they are satisfied with theavailability and cost of topical therapy for acute treatment, they continue toseek an effective systemic agent for maintenance therapy of this chronicdisorder," said Greg Dwyer, analyst at Decision Resources. "There arecurrently no drugs in development that address this unmet need."
About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in marketresearch publications, advisory services and consulting designed to helpclients shape strategy, allocate resources and master their chosen markets.Decision Resources is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offersbest-in-class, high-value information and insights on important sectors of thehealthcare industry. Clients rely on this analysis and data to make informeddecisions. Please visit Decision Resources, Inc. atwww.DecisionResourcesInc.com
All company, brand, or product names contained in this document may betrademarks or registered trademarks of their respective holders.For more information, contact: Decision Resources Decision Resources, Inc. Christopher Comfort Elizabeth Marshall 781-296-2597 781-296-2563 [email protected] [email protected]
SOURCE Decision Resources
